BioCentury | Oct 30, 2014
Strategy

Bayer's Bay Area formula

...capacity and has also rented space to Xcell Biosciences Inc. , Cairn Biosciences Inc. , Factor 14 Inc....
...Portland, Ore. Bayer AG (Xetra:BAYN), Leverkusen, Germany Cairn Biosciences Inc. , San Francisco, Calif. Factor 14 Inc....
BioCentury | Jun 10, 2013
Clinical News

Iclusig ponatinib: Additional Phase II data

Additional data from 449 patients in the single-arm, international, pivotal Phase II PACE trial showed that once-daily 45 mg oral Iclusig led to treatment-emergent serious arterial thrombotic events, including 21 cardiovascular and 14 cerebrovascular or...
Items per page:
1 - 2 of 2
BioCentury | Oct 30, 2014
Strategy

Bayer's Bay Area formula

...capacity and has also rented space to Xcell Biosciences Inc. , Cairn Biosciences Inc. , Factor 14 Inc....
...Portland, Ore. Bayer AG (Xetra:BAYN), Leverkusen, Germany Cairn Biosciences Inc. , San Francisco, Calif. Factor 14 Inc....
BioCentury | Jun 10, 2013
Clinical News

Iclusig ponatinib: Additional Phase II data

Additional data from 449 patients in the single-arm, international, pivotal Phase II PACE trial showed that once-daily 45 mg oral Iclusig led to treatment-emergent serious arterial thrombotic events, including 21 cardiovascular and 14 cerebrovascular or...
Items per page:
1 - 2 of 2